Literature DB >> 24503100

Antiretroviral therapy partly reverses the systemic and mucosal distribution of NK cell subsets that is altered by SIVmac₂₅₁ infection of macaques.

Namal P M Liyanage1, Shari N Gordon1, Melvin N Doster1, Poonam Pegu1, Monica Vaccari1, Nebiyu Shukur1, Luca Schifanella1, Cynthia A Pise-Masison1, Danuta Lipinska2, Kamil Grubczak3, Marcin Moniuszko4, Genoveffa Franchini5.   

Abstract

We characterized three subsets of NK cells in blood, and two subsets in mucosal tissues. SIVmac251 infection increased total and CD16(+) NK cells in the blood. In the rectum, we observed a significant increase in total and NKG2A(+) NK cells during SIV infection. In contrast, the NKp44(+) subset significantly depleted in acute infection and continued to decline in frequency during chronic phase. During SIV infection, blood CD16 and mucosal NKG2A(+) subsets had increased cytotoxic potential. Intriguingly, the NKp44(+) NK cell subtype that likely mediates mucosal homeostasis via the production of cytokines, acquired cytotoxicity. Antiretroviral therapy significantly increased the frequency of mucosal NKG2A(+) NK cells and peripheral CD16(+) NK cells. However, it failed to restore the normal frequency of NKp44(+) NK cells in the rectum. Thus, SIVmac251 infection causes changes in the distribution and function of NK cells and antiretroviral therapy during chronic infection only partially restores NK homeostasis and function.
© 2013 Published by Elsevier Inc.

Entities:  

Keywords:  ART; Chemokine receptor; HAART; HIV; Innate immunity; Innate lymphoid cells; Macaques; Mucosal; NK cell; SIV

Mesh:

Substances:

Year:  2014        PMID: 24503100      PMCID: PMC5008240          DOI: 10.1016/j.virol.2013.12.003

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  43 in total

1.  IL-17-producing innate lymphoid cells are restricted to mucosal tissues and are depleted in SIV-infected macaques.

Authors:  H Xu; X Wang; D X Liu; T Moroney-Rasmussen; A A Lackner; R S Veazey
Journal:  Mucosal Immunol       Date:  2012-06-06       Impact factor: 7.313

2.  CD16- natural killer cells: enrichment in mucosal and secondary lymphoid tissues and altered function during chronic SIV infection.

Authors:  R Keith Reeves; Jacqueline Gillis; Fay E Wong; Yi Yu; Michelle Connole; R Paul Johnson
Journal:  Blood       Date:  2010-03-25       Impact factor: 22.113

3.  Sequential deregulation of NK cell subset distribution and function starting in acute HIV-1 infection.

Authors:  Galit Alter; Nickolas Teigen; Benjamin T Davis; Marylyn M Addo; Todd J Suscovich; Michael T Waring; Hendrik Streeck; Mary N Johnston; Kyle D Staller; M Tauheed Zaman; Xu G Yu; Mathias Lichterfeld; Nesli Basgoz; Eric S Rosenberg; Marcus Altfeld
Journal:  Blood       Date:  2005-07-07       Impact factor: 22.113

4.  Antibody-dependent cellular cytotoxicity-mediating antibodies from an HIV-1 vaccine efficacy trial target multiple epitopes and preferentially use the VH1 gene family.

Authors:  Mattia Bonsignori; Justin Pollara; M Anthony Moody; Michael D Alpert; Xi Chen; Kwan-Ki Hwang; Peter B Gilbert; Ying Huang; Thaddeus C Gurley; Daniel M Kozink; Dawn J Marshall; John F Whitesides; Chun-Yen Tsao; Jaranit Kaewkungwal; Sorachai Nitayaphan; Punnee Pitisuttithum; Supachai Rerks-Ngarm; Jerome H Kim; Nelson L Michael; Georgia D Tomaras; David C Montefiori; George K Lewis; Anthony DeVico; David T Evans; Guido Ferrari; Hua-Xin Liao; Barton F Haynes
Journal:  J Virol       Date:  2012-08-15       Impact factor: 5.103

Review 5.  Targeting early infection to prevent HIV-1 mucosal transmission.

Authors:  Ashley T Haase
Journal:  Nature       Date:  2010-03-11       Impact factor: 49.962

Review 6.  Innate immunity in acute HIV-1 infection.

Authors:  Persephone Borrow
Journal:  Curr Opin HIV AIDS       Date:  2011-09       Impact factor: 4.283

7.  Virologically suppressed HIV patients show activation of NK cells and persistent innate immune activation.

Authors:  Gregor F Lichtfuss; Wan-Jung Cheng; Yagmur Farsakoglu; Geza Paukovics; Reena Rajasuriar; Pushparaj Velayudham; Marit Kramski; Anna C Hearps; Paul U Cameron; Sharon R Lewin; Suzanne M Crowe; Anthony Jaworowski
Journal:  J Immunol       Date:  2012-06-27       Impact factor: 5.422

Review 8.  Th17 cells and regulatory T cells in elite control over HIV and SIV.

Authors:  Dennis J Hartigan-O'Connor; Lauren A Hirao; Joseph M McCune; Satya Dandekar
Journal:  Curr Opin HIV AIDS       Date:  2011-05       Impact factor: 4.283

9.  Decreased NK Cell FcRgamma in HIV-1 infected individuals receiving combination antiretroviral therapy: a cross sectional study.

Authors:  Edwin Leeansyah; Jingling Zhou; Geza Paukovics; Sharon R Lewin; Suzanne M Crowe; Anthony Jaworowski
Journal:  PLoS One       Date:  2010-03-10       Impact factor: 3.240

10.  The use of nonhuman primate models in HIV vaccine development.

Authors:  Cecilia Morgan; Marta Marthas; Christopher Miller; Ann Duerr; Cecilia Cheng-Mayer; Ronald Desrosiers; Jorge Flores; Nancy Haigwood; Shiu-Lok Hu; R Paul Johnson; Jeffrey Lifson; David Montefiori; John Moore; Marjorie Robert-Guroff; Harriet Robinson; Steven Self; Lawrence Corey
Journal:  PLoS Med       Date:  2008-08-12       Impact factor: 11.069

View more
  11 in total

1.  Differential Effect of Mucosal NKp44+ Innate Lymphoid Cells and Δγ Cells on Simian Immunodeficiency Virus Infection Outcome in Rhesus Macaques.

Authors:  Mohammad Arif Rahman; Eun-Ju Ko; Gospel Enyindah-Asonye; Sabrina Helmold Hait; Christopher Hogge; Ruth Hunegnaw; David J Venzon; Tanya Hoang; Marjorie Robert-Guroff
Journal:  J Immunol       Date:  2019-09-25       Impact factor: 5.422

2.  Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition.

Authors:  Monica Vaccari; Shari N Gordon; Slim Fourati; Luca Schifanella; Namal P M Liyanage; Mark Cameron; Brandon F Keele; Xiaoying Shen; Georgia D Tomaras; Erik Billings; Mangala Rao; Amy W Chung; Karen G Dowell; Chris Bailey-Kellogg; Eric P Brown; Margaret E Ackerman; Diego A Vargas-Inchaustegui; Stephen Whitney; Melvin N Doster; Nicolo Binello; Poonam Pegu; David C Montefiori; Kathryn Foulds; David S Quinn; Mitzi Donaldson; Frank Liang; Karin Loré; Mario Roederer; Richard A Koup; Adrian McDermott; Zhong-Min Ma; Christopher J Miller; Tran B Phan; Donald N Forthal; Matthew Blackburn; Francesca Caccuri; Massimiliano Bissa; Guido Ferrari; Vaniambadi Kalyanaraman; Maria G Ferrari; DeVon Thompson; Marjorie Robert-Guroff; Silvia Ratto-Kim; Jerome H Kim; Nelson L Michael; Sanjay Phogat; Susan W Barnett; Jim Tartaglia; David Venzon; Donald M Stablein; Galit Alter; Rafick-Pierre Sekaly; Genoveffa Franchini
Journal:  Nat Med       Date:  2016-05-30       Impact factor: 53.440

Review 3.  Innate Lymphoid Cells: Their Contributions to Gastrointestinal Tissue Homeostasis and HIV/SIV Disease Pathology.

Authors:  Joseph C Mudd; Jason M Brenchley
Journal:  Curr HIV/AIDS Rep       Date:  2019-06       Impact factor: 5.071

4.  Therapeutic envelope vaccination in combination with antiretroviral therapy temporarily rescues SIV-specific CD4⁺ T-cell-dependent natural killer cell effector responses in chronically infected rhesus macaques.

Authors:  Diego A Vargas-Inchaustegui; Peng Xiao; Thorsten Demberg; Ranajit Pal; Marjorie Robert-Guroff
Journal:  Immunology       Date:  2015-06       Impact factor: 7.397

Review 5.  Natural killer cells in HIV-1 infection and therapy.

Authors:  Joanna Mikulak; Ferdinando Oriolo; Elisa Zaghi; Clara Di Vito; Domenico Mavilio
Journal:  AIDS       Date:  2017-11-13       Impact factor: 4.177

6.  Hypercytotoxicity and rapid loss of NKp44+ innate lymphoid cells during acute SIV infection.

Authors:  Haiying Li; Laura E Richert-Spuhler; Tristan I Evans; Jacqueline Gillis; Michelle Connole; Jacob D Estes; Brandon F Keele; Nichole R Klatt; R Keith Reeves
Journal:  PLoS Pathog       Date:  2014-12-11       Impact factor: 6.823

7.  Progression to AIDS in SIV-Infected Rhesus Macaques is Associated with Distinct KIR and MHC class I Polymorphisms and NK Cell Dysfunction.

Authors:  Christina Albrecht; Dörthe Malzahn; Markus Brameier; Meike Hermes; Aftab A Ansari; Lutz Walter
Journal:  Front Immunol       Date:  2014-11-28       Impact factor: 7.561

Review 8.  Innate Lymphoid Cells in HIV/SIV Infections.

Authors:  Spandan V Shah; Cordelia Manickam; Daniel R Ram; R Keith Reeves
Journal:  Front Immunol       Date:  2017-12-13       Impact factor: 7.561

9.  Hallmarks of primate lentiviral immunodeficiency infection recapitulate loss of innate lymphoid cells.

Authors:  Joseph C Mudd; Kathleen Busman-Sahay; Sarah R DiNapoli; Stephen Lai; Virginia Sheik; Andrea Lisco; Claire Deleage; Brian Richardson; David J Palesch; Mirko Paiardini; Mark Cameron; Irini Sereti; R Keith Reeves; Jacob D Estes; Jason M Brenchley
Journal:  Nat Commun       Date:  2018-09-27       Impact factor: 14.919

10.  Engagement of monocytes, NK cells, and CD4+ Th1 cells by ALVAC-SIV vaccination results in a decreased risk of SIVmac251 vaginal acquisition.

Authors:  Giacomo Gorini; Slim Fourati; Monica Vaccari; Mohammad Arif Rahman; Shari N Gordon; Dallas R Brown; Lynn Law; Jean Chang; Richard Green; Fredrik Barrenäs; Namal P M Liyanage; Melvin N Doster; Luca Schifanella; Massimiliano Bissa; Isabela Silva de Castro; Robyn Washington-Parks; Veronica Galli; Deborah H Fuller; Sampa Santra; Michael Agy; Ranajit Pal; Robert E Palermo; Georgia D Tomaras; Xiaoying Shen; Celia C LaBranche; David C Montefiori; David J Venzon; Hung V Trinh; Mangala Rao; Michael Gale; Rafick P Sekaly; Genoveffa Franchini
Journal:  PLoS Pathog       Date:  2020-03-12       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.